Latest News

12.13.18

Bausch Health to Purchase Majority of Synergy Pharmaceuticals’ Assets, Including Trulance

Source: FirstWord

12.13.18

Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Potential Avastin Biosimilar

Source: Innovent Biologics

12.12.18

GenSight Biologics Reports Sustained Quality of Life Improvements at Week 72 of Phase 3 REVERSE Clinical Trial

Source: GenSight Biologics

12.11.18

Opternative Changes Names to Visibly To Better Reflect Eye Care Industry Partnerships

Source: Visibly

12.11.18

Wills Eye Hospital’s Training in Ophthalmology Voted #1 Top Eye Residency Program in Nation

Source: Wills Eye Hospital

12.11.18

Anthem Blue Cross Blue Shield Now Covering Avedro’s Corneal Cross-Linking Procedure

Source: Avedro

12.10.18

Ophthalmic Investment Funds Led by Retinal Gene Therapy Developers

Source: Market Scope

12.10.18

Santen Announces Scottish Medicines Consortium Approval of Verkazia for Severe Vernal Keratoconjunctivitis

Source: Santen

12.10.18

Alcon Introduces New Medical Affairs Website in North America, Expanding Support for Patient Care and Clinical Community

Source: Alcon

12.10.18

Akorn CEO Steps Down After Loss of $4.3 Billion Fresenius Deal

Source: Bloomberg

View more stories